Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restrictive Fluid Management in Septic Shock (FRESH Substudy)
NCT04282252Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Feb 2020
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in septic shock, sponsored by Karolinska Institutet. Primary endpoint: Myocardial injury (hsTnT). Started Feb 2020; status: completed.
02
Conditions
septic shock
Beyond the preview
Go deeper on NCT04282252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282252.